World Health Organization. Medication safety in polypharmacy: technical report: World Health Organization 2019.

Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. https://doi.org/10.1186/s12877-017-0621-2.

Article  PubMed  PubMed Central  Google Scholar 

Delara M, Murray L, Jafari B, et al. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022;22(1):601. https://doi.org/10.1186/s12877-022-03279-x.

Article  PubMed  PubMed Central  Google Scholar 

Mansur N, Weiss A, Beloosesky Y. Looking beyond polypharmacy: quantification of medication regimen complexity in the elderly. Am J Geriatr Pharmacother. 2012;10(4):223–9. https://doi.org/10.1016/j.amjopharm.2012.06.002.

Article  PubMed  Google Scholar 

Page AT, Clifford RM, Potter K, et al. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(3):583–623. https://doi.org/10.1111/bcp.12975.

Article  PubMed  PubMed Central  Google Scholar 

Gnjidic D, Tinetti M, Allore HG. Assessing medication burden and polypharmacy: finding the perfect measure. Expert Rev Clin Pharmacol. 2017;10(4):345–7. https://doi.org/10.1080/17512433.2017.1301206.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schmidt SJ, Wurmbach VS, Lampert A, et al. Individual factors increasing complexity of drug treatment—a narrative review. Eur J Clin Pharmacol. 2020;76(6):745–54. https://doi.org/10.1007/s00228-019-02818-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ab Rahman N, Lim MT, Thevendran S, et al. Medication regimen complexity and medication burden among patients with type 2 diabetes mellitus: a retrospective analysis. Front Pharmacol. 2022;13: 808190. https://doi.org/10.3389/fphar.2022.808190.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Libby AM, Fish DN, Hosokawa PW, et al. Patient-level medication regimen complexity across populations with chronic disease. Clin Ther. 2013;35(4):385–98 e1. https://doi.org/10.1016/j.clinthera.2013.02.019.

Tesfaye WH, Peterson GM, Castelino RL, et al. Medication regimen complexity and hospital readmission in older adults with chronic kidney disease. Ann Pharmacother. 2019;53(1):28–34. https://doi.org/10.1177/1060028018793419.

Article  PubMed  Google Scholar 

Paramore C, Levine L, Bagshaw E, et al. Patient- and caregiver-reported burden of transfusion-dependent β-thalassemia measured using a digital application. The Patient Patient-Centered Outcomes Res. 2021;14(2):197–208. https://doi.org/10.1007/s40271-020-00473-0.

Article  Google Scholar 

Weatherall DJ. The challenge of haemoglobinopathies in resource-poor countries. Br J Haematol. 2011;154(6):736–44. https://doi.org/10.1111/j.1365-2141.2011.08742.x.

Article  PubMed  Google Scholar 

Mohd Ibrahim H, Muda Z, Othman IS, et al. Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry. BMJ Open. 2020;10(6): e037974. https://doi.org/10.1136/bmjopen-2020-037974.

Article  PubMed  PubMed Central  Google Scholar 

Koohi F, Kazemi T, Miri-Moghaddam E. Cardiac complications and iron overload in beta thalassemia major patients—a systematic review and meta-analysis. Ann Hematol. 2019;98(6):1323–31. https://doi.org/10.1007/s00277-019-03618-w.

Article  CAS  PubMed  Google Scholar 

Delea TE, Edelsberg J, Sofrygin O, et al. Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. Transfusion. 2007;47(10):1919–29. https://doi.org/10.1111/j.1537-2995.2007.01416.x.

Article  CAS  PubMed  Google Scholar 

Sidhu S, Kakkar S, Dewan P, et al. Adherence to Iron Chelation Therapy and Its Determinants. Int J Hematol Oncol Stem Cell Res. 2021;15(1):27–34. https://doi.org/10.18502/ijhoscr.v15i1.5247.

Ministry of Health Malaysia. Management of transfusion dependent thalassaemia:Ministry of Health Malaysia. 2009.

Motta I, Mancarella M, Marcon A, et al. Management of age-associated medical complications in patients with β-thalassemia. Expert Rev Hematol. 2020;13(1):85–94. https://doi.org/10.1080/17474086.2020.1686354.

Article  CAS  PubMed  Google Scholar 

Taher AT, Cappellini MD. How I manage medical complications of β-thalassemia in adults. Blood. 2018;132(17):1781–91. https://doi.org/10.1182/blood-2018-06-818187.

Article  CAS  PubMed  Google Scholar 

Metz KR, Fish DN, Hosokawa PW, et al. Patient-level medication regimen complexity in patients with HIV. Ann Pharmacother. 2014;48(9):1129–37. https://doi.org/10.1177/1060028014539642.

Article  PubMed  Google Scholar 

von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg (London, England). 2014;12(12):1495–9. https://doi.org/10.1016/j.ijsu.2014.07.013.

Article  Google Scholar 

Zaman Huri H, Chai LL. Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. BMC Public Health. 2013;13(1):1192. https://doi.org/10.1186/1471-2458-13-1192.

Article  PubMed  PubMed Central  Google Scholar 

Griffith S. A review of the factors associated with patient compliance and the taking of prescribed medicines. Br J Gen Pract. 1990;40(332):114–6.

George J, Phun YT, Bailey MJ, et al. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369–76. https://doi.org/10.1345/aph.1D479.

Article  PubMed  Google Scholar 

Pharmaceutical Care Network Europe Association. Classification for Drug related problems V 9.1. 2020. https://www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdf. Accessed 28 Feb 2022.

Borgna-Pignatti C, Cappellini MD, De Stefano P, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054:40–7. https://doi.org/10.1196/annals.1345.006.

Article  CAS  PubMed  Google Scholar 

Altman DG, Bland JM. Diagnostic tests 3: receiver operating characteristic plots. BMJ. 1994;309(6948):188. https://doi.org/10.1136/bmj.309.6948.188.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Personal Social Psychol. 1986;51(6):1173–82. https://doi.org/10.1037//0022-3514.51.6.1173.

Article  CAS  Google Scholar 

Iacobucci D. Mediation analysis and categorical variables: the final frontier. J Consum Psychol. 2012;22(4):582–94. https://doi.org/10.1016/j.jcps.2012.03.006.

Article  Google Scholar 

Ayele AA, Tegegn HG, Ayele TA, et al. Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital. BMJ Open Diabetes Res Care. 2019;7(1): e000685. https://doi.org/10.1136/bmjdrc-2019-000685.

Article  PubMed  PubMed Central  Google Scholar 

Wimmer BC, Cross AJ, Jokanovic N, et al. Clinical outcomes associated with medication regimen complexity in older people: a systematic review. J Am Geriatr Soc. 2017;65(4):747–53. https://doi.org/10.1111/jgs.14682.

Article  PubMed  Google Scholar 

Hirsch JD, Metz KR, Hosokawa PW, et al. Validation of a patient-level medication regimen complexity index as a possible tool to identify patients for medication therapy management intervention. Pharmacotherapy. 2014;34(8):826–35. https://doi.org/10.1002/phar.1452.

Article  PubMed  PubMed Central  Google Scholar 

Wimmer BC, Dent E, Visvanathan R, et al. Polypharmacy and medication regimen complexity as factors associated with hospital discharge destination among older people: a prospective cohort study. Drugs Aging. 2014;31(8):623–30. https://doi.org/10.1007/s40266-014-0185-1.

Article  PubMed  Google Scholar 

Morillo-Verdugo R, Robustillo-Cortes MA, Abdel-Kader Martin L, et al. Determination of a cutoff value for medication regimen complexity index to predict polypharmacy in HIV+ older patient. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia. 2019;32(5):458–64.

CAS  PubMed  Google Scholar 

Ferreira JM, Galato D, Melo AC. Medication regimen complexity in adults and the elderly in a primary healthcare setting: determination of high and low complexities. Pharm Pract (Granada). 2015;13(4):659. https://doi.org/10.18549/PharmPract.2015.04.659.

Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155–67. https://doi.org/10.1016/S0140-6736(17)31822-6.

Article  PubMed  Google Scholar 

Carr E, Federman A, Dzahini O, et al. A multidimensional measure of polypharmacy for older adults using the health and retirement study. Sci Rep. 2021;11(1):8783. https://doi.org/10.1038/s41598-021-86331-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chat Chai AS, Draman N, Mohd Yusoff SS, et al. Non-compliance to iron chelation therapy in patients with transfusion-dependent thalassaemia. Pediatric Hematol Oncol J. 2021;6(4):207–15. https://doi.org/10.1016/j.phoj.2021.10.005.

Article  Google Scholar 

Paramore C, Levine L, Bagshaw E, et al. Patient- and caregiver-reported burden of transfusion-dependent β-thalassemia measured using a digital application. Patient. 2021;14(2):197–208. https://doi.org/10.1007/s40271-020-00473-0.

Article  PubMed  Google Scholar 

Yousuf R, Akter S, Wasek SM, et al. Thalassemia: a review of the challenges to the families and caregivers. Cureus. 2022;14(12): e32491. https://doi.org/10.7759/cureus.32491.

Article  PubMed  PubMed Central  Google Scholar